Cardinal Health, Inc. (NYSE:CAH) Shares Bought by Natixis Advisors LLC

Natixis Advisors LLC increased its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 10.0% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 507,378 shares of the company's stock after purchasing an additional 45,929 shares during the quarter. Natixis Advisors LLC owned approximately 0.21% of Cardinal Health worth $60,008,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CAH. Frazier Financial Advisors LLC raised its holdings in Cardinal Health by 69.8% in the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company's stock valued at $28,000 after acquiring an additional 104 shares during the last quarter. Promus Capital LLC acquired a new position in Cardinal Health in the fourth quarter valued at approximately $30,000. AM Squared Ltd purchased a new stake in Cardinal Health in the third quarter valued at $33,000. Kentucky Trust Co purchased a new stake in Cardinal Health in the 4th quarter valued at about $41,000. Finally, HHM Wealth Advisors LLC raised its stake in shares of Cardinal Health by 57.6% in the 4th quarter. HHM Wealth Advisors LLC now owns 394 shares of the company's stock valued at $47,000 after acquiring an additional 144 shares during the period. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Price Performance

Shares of CAH traded up $0.90 during midday trading on Thursday, reaching $133.02. The stock had a trading volume of 1,737,963 shares, compared to its average volume of 2,389,597. The company's fifty day simple moving average is $126.94 and its two-hundred day simple moving average is $119.78. The company has a market cap of $32.13 billion, a price-to-earnings ratio of 24.82, a PEG ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $133.11.

Remove Ads

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, beating analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. On average, sell-side analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be issued a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is 37.69%.

Wall Street Analyst Weigh In

CAH has been the topic of a number of research analyst reports. Wells Fargo & Company boosted their target price on Cardinal Health from $135.00 to $136.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 4th. Jefferies Financial Group raised Cardinal Health from a "hold" rating to a "buy" rating and increased their target price for the stock from $140.00 to $150.00 in a research note on Wednesday, February 5th. Evercore ISI raised Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 target price for the company in a research report on Tuesday, January 7th. Argus set a $148.00 price objective on shares of Cardinal Health in a research note on Tuesday, February 4th. Finally, Mizuho initiated coverage on shares of Cardinal Health in a research note on Wednesday, December 4th. They set an "outperform" rating and a $139.00 target price on the stock. Four research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $139.36.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.